Target intelligence / Profile preview

ribosomal protein L29 pseudogene 15 (RPL29P15)

Target
RPL29P15
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L29 pseudogene 15 (RPL29P15) is a processed pseudogene in the human genome corresponding to the ribosomal protein L29 gene family. Pseudogenes are generally regarded as non-functional genomic elements, produced by gene duplication or retrotransposition events, that do not encode a functional protein. There is no evidence RPL29P15 encodes a protein or is involved in any cellular function or disease pathway[4][5][6][1].

Other names
RPL29_4_582

Beyond the preview

Go deeper on ribosomal protein L29 pseudogene 15 (RPL29P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L29 pseudogene 15 (RPL29P15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call